ASX - By Stock
|
IMU |
Re:
March Roadshows
|
|
Ysardine
|
387 |
177K |
0 |
10/03/23 |
10/03/23 |
ASX - By Stock
|
387
|
177K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Enrolment Target Reached for INSIGHT-003 Trial in NSCLC
|
|
Ysardine
|
2 |
1.9K |
26 |
06/02/23 |
06/02/23 |
ASX - By Stock
|
2
|
1.9K
|
26
|
|
ASX - By Stock
|
RAD |
Re:
Ann: RAD201 HER2 nanobody demonstrates favourable tumor targeting
|
|
Ysardine
|
15 |
6.6K |
3 |
16/12/22 |
16/12/22 |
ASX - By Stock
|
15
|
6.6K
|
3
|
|
ASX - By Stock
|
CSS |
Re:
Ann: Change of Director's Interest Notice - T Dillon
|
|
Ysardine
|
1 |
1.1K |
1 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
1
|
1.1K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Positive New HER-Vaxx HERIZON Data Presented at ESMO Asia
|
|
Ysardine
|
71 |
39K |
44 |
05/12/22 |
05/12/22 |
ASX - By Stock
|
71
|
39K
|
44
|
|
Charts
|
IMU |
Re:
Outstanding news
|
|
Ysardine
|
4 |
1.8K |
8 |
05/12/22 |
05/12/22 |
Charts
|
4
|
1.8K
|
8
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Ysardine
|
35K |
17M |
1 |
15/11/22 |
15/11/22 |
Charts
|
35K
|
17M
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene onCARlytics with Estrella ARTEMIS T Cells SITC
|
|
Ysardine
|
79 |
49K |
16 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
79
|
49K
|
16
|
|
ASX - By Stock
|
IMU |
Re:
Ann: AGM ATTENDANCE
|
|
Ysardine
|
19 |
8.5K |
23 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
19
|
8.5K
|
23
|
|
ASX - By Stock
|
IMM |
Re:
Big week for us good guys...
|
|
Ysardine
|
9 |
4.9K |
18 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
9
|
4.9K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Abstract for Efti selected for SITC 2022 Press Conference
|
|
Ysardine
|
20 |
9.8K |
14 |
04/11/22 |
04/11/22 |
ASX - By Stock
|
20
|
9.8K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Late Breaking Abstract accepted for SITC Oral Presentation
|
|
Ysardine
|
14 |
7.2K |
24 |
03/11/22 |
03/11/22 |
ASX - By Stock
|
14
|
7.2K
|
24
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Becoming a substantial holder
|
|
Ysardine
|
84 |
32K |
8 |
22/09/22 |
22/09/22 |
ASX - By Stock
|
84
|
32K
|
8
|
|
ASX - By Stock
|
IMU |
Re:
Ann: IMUGENE ANNOUNCES A$80 MILLION INSTITUTIONAL PLACEMENT
|
|
Ysardine
|
327 |
155K |
11 |
13/09/22 |
13/09/22 |
ASX - By Stock
|
327
|
155K
|
11
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Dr Stephanie H. Astrow appointed VP, Translational Sciences
|
|
Ysardine
|
6 |
2.7K |
3 |
12/09/22 |
12/09/22 |
ASX - By Stock
|
6
|
2.7K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Dose Escalates in Phase I Clinical Trial of VAXINIA
|
|
Ysardine
|
104 |
65K |
34 |
01/09/22 |
01/09/22 |
ASX - By Stock
|
104
|
65K
|
34
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Cell therapy industry leader appointed Chief Medical Officer
|
|
Ysardine
|
10 |
4.0K |
5 |
25/07/22 |
25/07/22 |
ASX - By Stock
|
10
|
4.0K
|
5
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Investor webinar - RAD adds brain tumor technology
|
|
Ysardine
|
51 |
19K |
4 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
51
|
19K
|
4
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Change of Director's Interest Notice - LC
|
|
Ysardine
|
10 |
4.0K |
13 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
10
|
4.0K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces publication of ASCO 2022 abstracts
|
|
Ysardine
|
18 |
13K |
26 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
18
|
13K
|
26
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep to announce new TACTI-002 data at ASCO 2022
|
|
Ysardine
|
47 |
30K |
18 |
27/05/22 |
27/05/22 |
ASX - By Stock
|
47
|
30K
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Termination of Supply Agreement
|
|
Ysardine
|
448 |
257K |
4 |
02/05/22 |
02/05/22 |
ASX - By Stock
|
448
|
257K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Efti with Keytruda shows encouraging activity in lung cancer
|
|
Ysardine
|
19 |
9.6K |
13 |
30/03/22 |
30/03/22 |
ASX - By Stock
|
19
|
9.6K
|
13
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Trading Halt
|
|
Ysardine
|
11 |
4.0K |
7 |
23/03/22 |
23/03/22 |
ASX - By Stock
|
11
|
4.0K
|
7
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Extension of Closing Date for Retail Entitlement Offer
|
|
Ysardine
|
36 |
14K |
6 |
09/03/22 |
09/03/22 |
ASX - By Stock
|
36
|
14K
|
6
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Change in substantial holding - PH
|
|
Ysardine
|
3 |
1.4K |
7 |
03/03/22 |
03/03/22 |
ASX - By Stock
|
3
|
1.4K
|
7
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Change in substantial holding NT
|
|
Ysardine
|
21 |
8.0K |
3 |
28/02/22 |
28/02/22 |
ASX - By Stock
|
21
|
8.0K
|
3
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Entitlement Offer to raise approximately $18.1 million
|
|
Ysardine
|
78 |
26K |
9 |
21/02/22 |
21/02/22 |
ASX - By Stock
|
78
|
26K
|
9
|
|
ASX - By Stock
|
RAD |
Re:
RAD media
|
|
Ysardine
|
7 |
3.3K |
2 |
09/02/22 |
09/02/22 |
ASX - By Stock
|
7
|
3.3K
|
2
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Encouraging data from 2nd dose cohort in CLTX CAR T trial
|
|
Ysardine
|
27 |
8.1K |
7 |
08/02/22 |
08/02/22 |
ASX - By Stock
|
27
|
8.1K
|
7
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Radiopharm and TerraPower sign Actinium 225 agreement
|
|
Ysardine
|
14 |
4.5K |
1 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
14
|
4.5K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Radiopharm and TerraPower sign Actinium 225 agreement
|
|
Ysardine
|
14 |
4.5K |
2 |
01/02/22 |
01/02/22 |
ASX - By Stock
|
14
|
4.5K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
Ysardine
|
382 |
197K |
3 |
18/01/22 |
18/01/22 |
ASX - By Stock
|
382
|
197K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Ysardine
|
15K |
7.6M |
14 |
15/01/22 |
15/01/22 |
ASX - By Stock
|
15K
|
7.6M
|
14
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Ysardine
|
15K |
7.6M |
65 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
15K
|
7.6M
|
65
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Release of Securities from Escrow
|
|
Ysardine
|
30 |
16K |
1 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
30
|
16K
|
1
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Change of Director's Interest Notice - RC
|
|
Ysardine
|
1 |
939 |
5 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
1
|
939
|
5
|
|
ASX - By Stock
|
LYC |
Re:
Ann: Update on Malaysian PDF for WLP Residue
|
|
Ysardine
|
22 |
15K |
41 |
30/12/21 |
30/12/21 |
ASX - By Stock
|
22
|
15K
|
41
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
Ysardine
|
2.9K |
1.2M |
7 |
23/12/21 |
23/12/21 |
ASX - By Stock
|
2.9K
|
1.2M
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Appendix 2A and IMUOB Option Underwriting Agreement
|
|
Ysardine
|
42 |
21K |
19 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
42
|
21K
|
19
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Change of Registered Office Address
|
|
Ysardine
|
20 |
6.5K |
3 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
20
|
6.5K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Change of Registered Office Address
|
|
Ysardine
|
20 |
6.5K |
2 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
20
|
6.5K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
Ysardine
|
59 |
30K |
17 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
59
|
30K
|
17
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Change of Director's Interest Notice - IT
|
|
Ysardine
|
1 |
945 |
4 |
13/12/21 |
13/12/21 |
ASX - By Stock
|
1
|
945
|
4
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Letter to shareholders
|
|
Ysardine
|
11 |
4.7K |
7 |
10/12/21 |
10/12/21 |
ASX - By Stock
|
11
|
4.7K
|
7
|
|
ASX - By Stock
|
RAD |
Re:
Ann: Letter to shareholders
|
|
Ysardine
|
11 |
4.7K |
5 |
10/12/21 |
10/12/21 |
ASX - By Stock
|
11
|
4.7K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Clinicaltrials.gov has CF33-hNIS-antiPDL1 for Triple Negative Breast Cancer trial listed
|
|
Ysardine
|
130 |
86K |
45 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
130
|
86K
|
45
|
|
ASX - By Stock
|
CHM |
Re:
Ann: CHM 1101 data accepted for presentation at SNO meeting
|
|
Ysardine
|
123 |
35K |
15 |
15/11/21 |
15/11/21 |
ASX - By Stock
|
123
|
35K
|
15
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
Ysardine
|
15K |
7.6M |
51 |
11/11/21 |
11/11/21 |
ASX - By Stock
|
15K
|
7.6M
|
51
|
|
Charts
|
IMU Biotech |
Re:
IMUGENE CHART. TA only
|
|
Ysardine
|
35K |
17M |
6 |
01/11/21 |
01/11/21 |
Charts
|
35K
|
17M
|
6
|
|